
Divij
@divijmathew
PostDoc in the Wherry Lab @ UPenn.
ID: 76534093
http://www.linkedin.com/in/divijmathew 23-09-2009 02:30:56
129 Tweet
240 Followers
290 Following

Our review is out in Immunity reviewing CD8 T cells in the Cancer-Immunity Cycle! A wonderful anniversary issue with reviews covering many aspects of the CIC originally described by Dan Chen and Ira Mellman. Wonderful working with Anna-Maria Globig Kaechlab (Sue Kaech) E. John Wherry!

Scenes from Society for Immunotherapy of Cancer Annual Conference in San Diego. Excellent science, and thrilled to chair the Oral Abstract Session. Penn Medicine - Abramson Cancer Center’s very own Divij from E. John Wherry lab presenting elegant science on FLT3 in NSCLC! Al Garfall Robert Ferris, MD, PhD Diwakar Davar, M.D. Missed




Summary of our paper scim.ag/7p1 on combining JAK inhibitors with anti-PD1 for lung cancer (NSCLC). Part of a bench-to-bedside journey to understand opposing roles of IFN in IO. Wonderful team w E. John Wherry Divij Caitlin Foley Melina Marmarelis Joshua Bauml, MD et al! 1/13


🚀Very excited to announce that the Apostolidis Lab will open up its doors on July 1st Penn Medicine! We will be focusing our efforts on understanding fundamental drivers of autoimmunity using unique human cohorts and mechanistic mouse models. #Autoimmunity #Rheumatology


New research from Penn Medicine in Science Magazine, led by PICI Investigators, shows promising results for advanced #NSCLC treatment in a Ph 2 trial: science.org/doi/10.1126/sc… (1/4)



Excited to share my graduate work from the E. John Wherry lab on the molecular mechanisms locking in the differentiation fate of exhausted CD8 T cells (Tex), published earlier this month in @SciImmuno. Main findings below! science.org/doi/10.1126/sc…
